US Patent 7304060 Indazolyl-substituted pyrroline compounds as kinase inhibitors
Patent 7304060 was granted and assigned to Ortho-McNeil Pharmaceutical on December, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Bruce Conway0
Bruce Maryanoff0
David F. McComsey0
Han-Cheng Zhang0
Hong Ye0
Kimberly White0
Leonard Robert Hecker0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+115 characters)
Article
Patent abstract
The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I):
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07304060 Indazolyl-substituted pyrroline compounds as kinase inhibitors US Patent 7304060 Indazolyl-substituted pyrroline compounds as kinase inhibitors
Infobox
Patent Number
073040600
Patent Number
73040600
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073040600
Date of Patent
December 4, 2007
0Patent Application Number
108853730
Date Filed
July 6, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07304060 Indazolyl-substituted pyrroline compounds as kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07304060
Date of patent
December 4, 2007
Patent application number
10885373
Date Filed
July 6, 2004
Patent primary examiner
Find more entities like US Patent 7304060 Indazolyl-substituted pyrroline compounds as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.